Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Moxham Christopher
Chief Scientific Officer at Fulcrum Therapeutics. Filing since 10 Aug 2021.
CIK 0001843784
Company
Date
Role
Action
Shares
Amount
Of holding
FULC
Fulcrum Therapeutics, Inc.
10 Aug 2021
Chief Scientific Officer
Sold, plan not stated
31,071
$559.28K
100%
FULC
Fulcrum Therapeutics, Inc.
10 Aug 2021
Chief Scientific Officer
Sold, plan not stated
20,714
$352.14K
100%
2 decisions on file.
